1. 116: Fighting Prostate Cancer with our Eyes Open: Impact of MRI Staging on Risk Assessment and Radiation Therapy. (September 2016) Authors: McGuffin, Merrylee; Ji, Chen; Bristow, Bonnie; Loblaw, Andrew Journal: Radiotherapy and oncology Issue: Volume 120(2016)Supplement 1 Page Start: S43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 14: Learning in 360 Degrees: The Use of Virtual Reality for Radiation Therapy Patient Education. (October 2021) Authors: McGuffin, Merrylee; Liszewski, Brian; Dawdy, Krista; Di Prospero, Lisa; Lai, Yannie; Alam, Fahad Journal: Radiotherapy and oncology Issue: Volume 163(2021)Supplement 1 Page Start: S9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 15: A Comparison of Three Different Breath Hold Techniques Used for Reducing Cardiac Dose for Patients Receiving Left-Sided Breast Cancer Radiation Therapy. (September 2022) Authors: Hoang, Anh; Wronski, Matt; McGuffin, Merrylee; Kager, Nelly; Cumal, Aaron; Nathoo, Dilshad; Bola, Ruby; Vesprini, Danny; Kim, Anthony; McCann, Claire; Keller, Brian; Sheikh, Aisha; Gallant, Francois; Liszewski, Brian; Karam, Irene Journal: Radiotherapy and oncology Issue: Volume 174(2022)Supplement 1 Page Start: S9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 5: Biochemical Failure and Toxicity of Magnetic Resonance Imaging Dose Painting to Dominant Intraprostatic Lesion in Prostate High Dose Rate Brachytherapy. (October 2021) Authors: Cozma, Adrian; Lai, Wing Yan; McGuffin, Merrylee; Erler, Darby; Morton, Gerard; Chung, Hans; Tseng, Chia-Lin; Zhang, Liying; Cheung, Patrick; Chu, William; Vesprini, Danny; Davidson, Melanie; Ravi, Ananth; Korol, Renee; Loblaw, Andrew Journal: Radiotherapy and oncology Issue: Volume 163(2021)Supplement 1 Page Start: S5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 80 Toxicity and Quality of Life Results from a Randomized Phase II Trial of HDR Monotherapy for Low and Intermediate-Risk Prostate Cancer. (October 2019) Authors: Hasan, Yaser; Loblaw, Andrew; Chung, Hans; McGuffin, Merrylee; Tseng, Chia-Lin; Mendez, Lucas; Ravi, Ananth; Zhang, Liying; Mamedov, Alexandre; Morton, Gerard Journal: Radiotherapy and oncology Issue: Volume 139(2019)Supplement 1 Page Start: S36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 87 High Dose-Rate Brachytherapy as Monotherapy for Prostate Cancer: One Fraction May Not Be Enough. (October 2019) Authors: Morton, Gerard; McGuffin, Merrylee; Chung, Hans; Tseng, Eric; Mendez, Lucas; Hasan, Yaser; Ravi, Ananth; Zhang, Liying; Loblaw, Andrew Journal: Radiotherapy and oncology Issue: Volume 139(2019)Supplement 1 Page Start: S39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 8: Dosimetric Predictors of Toxicity and Quality of Life Following Single Fraction High Dose-Rate Prostate Brachytherapy. (October 2021) Authors: Corkum, Mark T.; Loblaw, Andrew; Chung, Hans T.; Tseng, Chia-Lin; McGuffin, Merrylee; Davidson, Melanie; Paudel, Moti; Wronski, Matt; Cheung, Patrick; Chu, William; Szumacher, Ewa; Zhang, Liying; Mamedov, Alexandre; Morton, Gerard Journal: Radiotherapy and oncology Issue: Volume 163(2021)Supplement 1 Page Start: S7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. MRI assisted focal boost integrated with HDR monotherapy study in low and intermediate risk prostate cancer (MARS): Results from a phase II clinical trial. (December 2019) Authors: Alayed, Yasir; D'Alimonte, Laura; Helou, Joelle; Ravi, Ananth; Morton, Gerard; Chung, Hans T.; Haider, Masoom; McGuffin, Merrylee; Zhang, Liying; Loblaw, Andrew Journal: Radiotherapy and oncology Issue: Volume 141(2019) Page Start: 144 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Early toxicity and quality-of life results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions of 13.5 Gy. Issue 1 (January 2017) Authors: Morton, Gerard; Chung, Hans T.; McGuffin, Merrylee; Helou, Joelle; D'Alimonte, Laura; Ravi, Ananth; Cheung, Patrick; Szumacher, Ewa; Liu, Stanley; Al-Hanaqta, Motasem; Zhang, Liying; Mamedov, Alexandre; Loblaw, Andrew Journal: Radiotherapy and oncology Issue: Volume 122:Issue 1(2017:Jan.) Page Start: 87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Efficacy results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions of 13.5 Gy. (May 2020) Authors: Morton, Gerard; McGuffin, Merrylee; Chung, Hans T.; Tseng, Chia-Lin; Helou, Joelle; Ravi, Ananth; Cheung, Patrick; Szumacher, Ewa; Liu, Stanley; Chu, William; Zhang, Liying; Mamedov, Alexandre; Loblaw, Andrew Journal: Radiotherapy and oncology Issue: Volume 146(2020) Page Start: 90 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗